Skip to content

Observation on the Application Effect of External Application of Rheumatism-dispelling Medicine in Patients with Acute Gouty Arthritis

Observation on the Application Effect of External Application of Rheumatism-dispelling Medicine in Patients with Acute Gouty Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001527
Enrollment
Unknown
Registered
2025-07-30
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Gouty Arthritis

Interventions

Control group:Routine in-hospital care
Intervention Group:Based on control group protocols with additional herbal external application

Sponsors

The Central Hospital of WuHan Tongji Medical College Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria:(2)Aged between 18 and 85 years;(2)Meeting the diagnostic criteria for gouty arthritis according to Western medicine standards;(3)No intellectual disabilities;4()Normal language communication abilities;(5)Voluntary participation with written informed consent obtained under full comprehension.

Exclusion criteria

Exclusion criteria: Exclusion Criteria:(1)Presence of concomitant severe cardiovascular hepatic renal or other systemic diseases; (2)Pregnant or lactating women;(3)History of hypersensitivity or known allergies to any formulation components; (4)Tophaceous deposits complicated by extensive skin infections or ulcerations.

Design outcomes

Primary

MeasureTime frame
Joint Swelling Severity;VAS pain score;Joint Erythema Severity;Pain Days;

Countries

China

Contacts

Public ContactFang Xu

The Central Hospital of WuHan Tongji Medical College Huazhong University of Science and Technology

453328433@qq.com18040503280

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026